This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Medical Practice  • Law and Medicine  • Oncology  • Cervical Cancer  • Immunization  • Women's Health  • Women's Health, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Public Health vs Private Wealth

Lawrence O. Gostin, JD, LLD; Catherine D. DeAngelis, MD, MPH

JAMA. 2007;297:1921-1923.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

By any measure, genital human papillomavirus (HPV) infection and HPV-associated cervical cancer are significant national and global public health concerns. An estimated 11 000 newly diagnosed cases of cervical cancer occur annually in the United States, resulting in 3700 deaths.¹ Globally, an estimated 493 000 new cervical cancer cases occur each year, with 274 000 deaths; more than 80% of cervical cancer deaths worldwide occur in developing countries.²

Human papillomavirus is the most common sexually transmitted infection in the United States, with an estimated 6.2 million individuals newly infected annually.³ Data from the National Health and Nutrition Examination Survey revealed a 26.8% overall HPV prevalence among US girls and women, with increasing prevalence each year for ages 14 to 24 years (44.8% for ages 20-24 years) followed by a gradual decline in prevalence through age 59 years (19.6% for ages 50-59 years).⁴ Although . . . [Full Text of this Article]

Author Affiliations: Georgetown Law Center, Washington, DC (Dr Gostin). Dr DeAngelis is Editor in Chief, JAMA.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Marketing HPV Vaccine: Implications for Adolescent Health and Medical Professionalism
Rothman and Rothman
JAMA 2009;302:781-786.
ABSTRACT | FULL TEXT  

The Moral Justification for a Compulsory Human Papillomavirus Vaccination Program
Balog
AJPH 2009;99:616-622.
ABSTRACT | FULL TEXT  

Human Papillomavirus Quadrivalent Vaccine: A Look Behind The Numbers
Flaherty and Alkhateeb
The Annals of Pharmacotherapy 2009;43:740-744.
ABSTRACT | FULL TEXT  

Ethics and the HPV Vaccine: Considerations for School Nurses
Bennett
The Journal of School Nursing 2008;24:275-283.
ABSTRACT | FULL TEXT  

Medical Accuracy in Sexuality Education: Ideology and the Scientific Process
Santelli
AJPH 2008;98:1786-1792.
ABSTRACT | FULL TEXT  

A Critique of Criteria for Evaluating Vaccines for Inclusion in Mandatory School Immunization Programs
Opel et al.
Pediatrics 2008;122:e504-e510.
ABSTRACT | FULL TEXT  

Human papillomavirus vaccination programmes
Lo
BMJ 2007;335:357-358.
FULL TEXT  

In This Issue: Clinical Diagnosis and Management
Stange
Ann Fam Med 2007;5:290-291.
FULL TEXT  

JAMA's Contributing Writers
DeAngelis and Fontanarosa
JAMA 2007;297:2139-2140.
FULL TEXT